Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Telehealth Digital Health Financing

Glooko Raises $30M To Accelerate Commercial Strategy, R&D, Tuck-In Acquisitions

  • News

Executive Summary

Glooko will use the proceeds to expand into new geographies and take advantage of rising reimbursement for digital health, expand solutions for co-morbid conditions, and explore tuck-in acquisitions.

You may also be interested in...



ADA 2021: Encouraging Trial Data On CGMs, Insulin Pens, Digital Solutions, And More

The American Diabetes Association held its 81st Scientific Sessions from 25-29 June, where a range of presentations covering clinical trials of continuous glucose monitors, insulin-delivery systems and remote monitoring technologies were given.

Lilly Signs Deals With Dexcom, Glooko, myDiabby, Roche For Diabetes Management Solutions

Lilly announced it signed strategic international agreements with four diabetes companies to advance connected solutions and streamline care for people with diabetes in markets outside of the US.

Digital Health Roundup, March 2021: Record-Breaking Funding; Exec Chats With Medtronic, Edwards LifeSciences

In this new roundup feature focusing on the most notable developments in digital health, we pick the key news to date.

Table

View full table

Related Content

Medtech Insight
Medtech Insight
Medtech Insight

Topics

Related Companies

Tags:
Telehealth Digital Health Financing
Latest Headlines

Intarcia’s Implantable GLP-1 Gets Unanimous No Vote But Lots Of New Trial Design Advice

Class I Recall For Medline’s Saline Solution Packs

News We're Watching: Studies Back Nevro Pain Treatment, FTC Blesses Resonetics Nitinol Deal, Genetic Test Identifies Best RDN Patients

Getting Personal With Tom Miller: CEO Turned VC On Ethical Bets In Diagnostics

See All
UsernamePublicRestriction

Register

MT143655

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By